Related Experiment Video
Updated: Mar 30, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair
Firas L Tarish1, Niklas Schultz2, Anna Tanoglidi3
1Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden. Department of Urology, Central Hospital, 721 89 Västerås, Sweden.
Abstract:
Chemical castration improves responses to radiotherapy in prostate cancer, but the mechanism is unknown. We hypothesized that this radiosensitization is caused by castration-mediated down-regulation of nonhomologous end joining (NHEJ) repair of DNA double-strand breaks (DSBs). To test this, we enrolled 48 patients with localized prostate cancer in two arms of the study: either radiotherapy first or radiotherapy after neoadjuvant castration treatment. We biopsied patients at diagnosis and before and after castration and radiotherapy treatments to monitor androgen receptor, NHEJ, and DSB repair in verified cancer tissue. We show that patients receiving neoadjuvant castration treatment before radiotherapy had reduced amounts of the NHEJ protein Ku70, impaired radiotherapy-induced NHEJ activity, and higher amounts of unrepaired DSBs, measured by γ-H2AX foci in cancer tissues. This study demonstrates that chemical castration impairs NHEJ activity in prostate cancer tissue, explaining the improved response of patients with prostate cancer to radiotherapy after chemical castration.
Insights
Chemical castration enhances radiotherapy effectiveness in prostate cancer by reducing DNA repair. This treatment lowers nonhomologous end joining (NHEJ) activity, leading to more unrepaired DNA damage and better treatment outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Chemical castration is known to improve radiotherapy outcomes in prostate cancer patients.
- The underlying mechanism for this radiosensitization effect remains largely unknown.
- Nonhomologous end joining (NHEJ) is a primary pathway for repairing DNA double-strand breaks (DSBs) induced by radiotherapy.
Purpose of the Study:
- To investigate the hypothesis that chemical castration radiosensitizes prostate cancer by down-regulating NHEJ repair of DSBs.
- To elucidate the molecular mechanisms linking castration, DNA repair, and radiotherapy response in prostate cancer.
Main Methods:
- A study involving 48 patients with localized prostate cancer was conducted.
- Patients were assigned to two arms: radiotherapy first or radiotherapy after neoadjuvant castration.
- Biopsies were taken at diagnosis, pre- and post-castration, and post-radiotherapy to assess androgen receptor, NHEJ activity, and DSB repair markers (e.g., γ-H2AX foci).
Main Results:
- Neoadjuvant chemical castration significantly reduced the NHEJ protein Ku70 in prostate cancer tissues.
- Castration impaired radiotherapy-induced NHEJ activity.
- Higher levels of unrepaired DSBs, indicated by increased γ-H2AX foci, were observed in patients receiving castration before radiotherapy.
Conclusions:
- Chemical castration impairs the nonhomologous end joining (NHEJ) DNA repair pathway in prostate cancer cells.
- This impairment of NHEJ activity by castration contributes to the radiosensitization observed in prostate cancer patients.
- The findings provide a molecular explanation for improved radiotherapy responses following neoadjuvant chemical castration.
Related Concept Videos
Other Unique Bacteria
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

